Volume Spike Investor

Sequenom, Inc. (NASDAQ: SQNM) is continuing to hold up despite it being a ship with no real captains and no real crew.  There were earlier-week reports that it had met with the government over the debacle for its tests on reports that it met with the U.S. Attorney, the SEC and FBI to discuss the flawed clinical data used to back up the validity of its Down syndrome prenatal test.  This one rose over 10% yesterday to $3.28 on over 12 million shares and shares are up almost 6% at $3.47 on 135,000 shares as of 9:01 AM EST.  We’ll be keeping a close eye on this company, particularly as the company is now effectively an at-risk or going concern in our opinion.
JON C. OGG